133 related articles for article (PubMed ID: 36880215)
1. Comparing efficacy and safety of high-dose and standard-dose rifampicin in the treatment of brucellosis: a randomized clinical trial.
Salehi M; Farbod F; Khalili H; Rahmani H; Jafari S; Abbasi A
J Antimicrob Chemother; 2023 Apr; 78(4):1084-1091. PubMed ID: 36880215
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
[TBL] [Abstract][Full Text] [Related]
4. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
[TBL] [Abstract][Full Text] [Related]
5. Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis [ISRCTN31053647].
Alp E; Koc RK; Durak AC; Yildiz O; Aygen B; Sumerkan B; Doganay M
BMC Infect Dis; 2006 Apr; 6():72. PubMed ID: 16606473
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
[TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis.
Agalar C; Usubutun S; Turkyilmaz R
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):535-8. PubMed ID: 10517189
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis.
Shasha B; Lang R; Rubinstein E
J Antimicrob Chemother; 1994 Mar; 33(3):545-51. PubMed ID: 8040118
[TBL] [Abstract][Full Text] [Related]
9. Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin in the Treatment of Brucellosis Spondylitis.
Yang XM; Jia YL; Zhang Y; Zhang PN; Yao Y; Yin YL; Tian Y
Drug Des Devel Ther; 2021; 15():4733-4740. PubMed ID: 34848945
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous side effects of doxycycline: a pediatric case series.
Bayhan GI; Akbayram S; Ozaydin Yavuz G; Oner AF
Cutan Ocul Toxicol; 2017 Jun; 36(2):140-144. PubMed ID: 27292651
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three different combination therapies in the treatment of human brucellosis.
Ersoy Y; Sonmez E; Tevfik MR; But AD
Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
[TBL] [Abstract][Full Text] [Related]
13. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
14. A randomized, comparative study of dual therapy (doxycycline-rifampin) versus triple therapy (doxycycline-rifampin-levofloxacin) for treating acute/subacute brucellosis.
Hasanain A; Mahdy R; Mohamed A; Ali M
Braz J Infect Dis; 2016; 20(3):250-4. PubMed ID: 27086734
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two durations of triple-drug therapy in patients with uncomplicated brucellosis: A randomized controlled trial.
Sofian M; Velayati AA; Aghakhani A; McFarland W; Farazi AA; Banifazl M; Eslamifar A; Ramezani A
Scand J Infect Dis; 2014 Aug; 46(8):573-7. PubMed ID: 24934986
[TBL] [Abstract][Full Text] [Related]
16. Update on treatment options for spinal brucellosis.
Ulu-Kilic A; Karakas A; Erdem H; Turker T; Inal AS; Ak O; Turan H; Kazak E; Inan A; Duygu F; Demiraslan H; Kader C; Sener A; Dayan S; Deveci O; Tekin R; Saltoglu N; Aydın M; Horasan ES; Gul HC; Ceylan B; Kadanalı A; Karabay O; Karagoz G; Kayabas U; Turhan V; Engin D; Gulsun S; Elaldı N; Alabay S
Clin Microbiol Infect; 2014 Feb; 20(2):O75-82. PubMed ID: 24118178
[TBL] [Abstract][Full Text] [Related]
17. Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.
Akova M; Uzun O; Akalin HE; Hayran M; Unal S; Gür D
Antimicrob Agents Chemother; 1993 Sep; 37(9):1831-4. PubMed ID: 8239591
[TBL] [Abstract][Full Text] [Related]
18. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study.
Bayindir Y; Sonmez E; Aladag A; Buyukberber N
J Chemother; 2003 Oct; 15(5):466-71. PubMed ID: 14598939
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline and rifampicin for mild scrub-typhus infections in northern Thailand: a randomised trial.
Watt G; Kantipong P; Jongsakul K; Watcharapichat P; Phulsuksombati D; Strickman D
Lancet; 2000 Sep; 356(9235):1057-61. PubMed ID: 11009140
[TBL] [Abstract][Full Text] [Related]
20. Predictors of therapeutic failure among patients with acute brucellosis treated by dual therapy with doxycycline-rifampin.
Alsayed Hasanain AF; El-Masry MA; Zayed AAH; Nafee AMA; Attia RAH; Abdel-Aal SM
Trop Med Int Health; 2019 Feb; 24(2):185-191. PubMed ID: 30411836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
